InsiderClue

Insider trading

Period: 120 months Stock: EOLS Role: 10% owners × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
When Periodin use
Who Rolein use
The trade Type of trade Minimum amount Plan Share of their own holding
Ownership What the chief executive holds
When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

1 month 12 months 120 months
33 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

Anyone CEO CFO Other officers Directors 10% owners
33 decisions over 120 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

Any33 Buys15 Sells18 Cluster buys
33 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

Any $100K or more $1M or more $10M or more $100M or more $500M or more
33 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
Any Discretionary Scheduled (10b5-1) Not stated Not on a plan
33 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
33 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

33 decisions over 120 months
Stock
Insider
Type ?
Value ↓
Of own stake ↓
Why it stands out
EOLS Evolus, Inc.
16 Oct 2023
Medytox Inc. Former 10% Owner
Sold at will
$12.68M 1,690,663 at 7.50
33.3%
Not planned
EOLS Evolus, Inc.
17 Feb 2023
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$15.54M 1,850,000 at 8.40
30.5%
EOLS Evolus, Inc.
7 Feb 2023
Medytox Inc. 10% owner
Sold, plan not stated
$18.59M 2,187,511 at 8.50
30.1%
EOLS Evolus, Inc.
20 Jan 2023
Medytox Inc. 10% owner · indirect
Sold, plan not stated
$408.95K 37,043 at 11.04
0.5%
EOLS Evolus, Inc.
6 Oct 2022
Medytox Inc. 10% owner
Sold, plan not stated
$344.42K 38,304 at 8.99
0.5%
EOLS Evolus, Inc.
5 Oct 2022
Medytox Inc. 10% owner
Sold, plan not stated
$61.29K 6,848 at 8.95
0.1%
EOLS Evolus, Inc.
15 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$248.10K 24,000 at 10.34
0.3%
EOLS Evolus, Inc.
14 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$749.67K 73,000 at 10.27
1.0%
EOLS Evolus, Inc.
9 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$217.91K 20,700 at 10.53
0.3%
EOLS Evolus, Inc.
8 Sep 2022
Medytox Inc. 10% owner
Sold, plan not stated
$158.98K 15,300 at 10.39
0.2%
EOLS Evolus, Inc.
1 Aug 2022
Medytox Inc. 10% owner
Sold, plan not stated
$345.36K 26,000 at 13.28
0.3%
EOLS Evolus, Inc.
2 Sep 2021
Alphaeon 1 LLC 10% owner
Sold, plan not stated
$24.68M 2,597,475 at 9.50
30.0%
EOLS Evolus, Inc.
27 Aug 2021
Medytox Inc. 10% owner
Bought
$557.57K 51,000 at 10.93
0.7%
EOLS Evolus, Inc.
26 Aug 2021
Medytox Inc. 10% owner
Bought
$727.41K 66,000 at 11.02
0.9%
EOLS Evolus, Inc.
25 Aug 2021
Medytox Inc. 10% owner
Bought
$489.39K 44,000 at 11.12
0.6%
EOLS Evolus, Inc.
24 Aug 2021
Medytox Inc. 10% owner
Bought
$807.03K 72,219 at 11.17
1.0%
Largest buy in 3 yrs
EOLS Evolus, Inc.
23 Aug 2021
Medytox Inc. 10% owner
Bought
$769.78K 69,781 at 11.03
1.0%
Largest buy in 3 yrs
EOLS Evolus, Inc.
20 Aug 2021
Medytox Inc. 10% owner
Bought
$506.70K 48,000 at 10.56
0.7%
EOLS Evolus, Inc.
19 Aug 2021
Medytox Inc. 10% owner
Bought
$578.11K 55,000 at 10.51
0.8%
EOLS Evolus, Inc.
18 Aug 2021
Medytox Inc. 10% owner
Bought
$474.08K 45,000 at 10.54
0.6%
EOLS Evolus, Inc.
17 Aug 2021
Medytox Inc. 10% owner
Bought
$748.06K 70,000 at 10.69
1.0%
Largest buy in 3 yrs
EOLS Evolus, Inc.
16 Aug 2021
Medytox Inc. 10% owner
Bought
$737.04K 65,000 at 11.34
0.9%
Largest buy in 3 yrs
EOLS Evolus, Inc.
13 Aug 2021
Medytox Inc. 10% owner
Bought
$545.72K 49,714 at 10.98
0.7%
Largest buy in 3 yrs
EOLS Evolus, Inc.
13 Aug 2021
Medytox Inc. 10% owner · indirect
Bought
$156.06K 14,043 at 11.11
0.2%
EOLS Evolus, Inc.
12 Aug 2021
Medytox Inc. 10% owner
Bought
$427.71K 39,126 at 10.93
0.6%
Largest buy in 3 yrs
EOLS Evolus, Inc.
12 Aug 2021
Medytox Inc. 10% owner · indirect
Bought
$252.77K 23,000 at 10.99
0.3%
EOLS Evolus, Inc.
11 Aug 2021
Medytox Inc. 10% owner
Bought
$281.74K 26,160 at 10.77
0.4%
First buy on file
EOLS Evolus, Inc.
3 Jun 2019
AEON Biopharma, Inc. 10% owner
Sold, plan not stated
$25.00M 1,298,701 at 19.25
13.0%
EOLS Evolus, Inc.
22 May 2019
AEON Biopharma, Inc. 10% owner
Sold, plan not stated
$5.59M 290,518 at 19.25
2.8%
EOLS Evolus, Inc.
20 May 2019
AEON Biopharma, Inc. 10% owner
Sold, plan not stated 2×
$96.59M 5,017,422 at 19.25
32.9%
EOLS Evolus, Inc.
29 Nov 2018
AEON Biopharma, Inc. 10% owner
Sold, plan not stated
$8.03M 573,888 at 14.00
3.6%
EOLS Evolus, Inc.
11 Sep 2018
AEON Biopharma, Inc. 10% owner
Sold, plan not stated
$36.82M 1,750,000 at 21.04
9.9%
EOLS Evolus, Inc.
23 Jul 2018
AEON Biopharma, Inc. 10% owner
Sold, plan not stated
$18.80M 1,000,000 at 18.80
5.4%
Showing 1–33 of 33.